nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Cardiac arrest—Fingolimod—multiple sclerosis	0.0119	0.0254	CcSEcCtD
Levorphanol—OPRM1—nerve—multiple sclerosis	0.011	0.215	CbGeAlD
Levorphanol—Injection site reaction—Cladribine—multiple sclerosis	0.00972	0.0207	CcSEcCtD
Levorphanol—Bradycardia—Fingolimod—multiple sclerosis	0.00882	0.0188	CcSEcCtD
Levorphanol—Lethargy—Cladribine—multiple sclerosis	0.00725	0.0155	CcSEcCtD
Levorphanol—Palpitations—Fingolimod—multiple sclerosis	0.00667	0.0142	CcSEcCtD
Levorphanol—Hypotension—Fingolimod—multiple sclerosis	0.00575	0.0123	CcSEcCtD
Levorphanol—Renal failure—Cladribine—multiple sclerosis	0.00538	0.0115	CcSEcCtD
Levorphanol—Hypoxia—Methotrexate—multiple sclerosis	0.00504	0.0108	CcSEcCtD
Levorphanol—OPRM1—brainstem—multiple sclerosis	0.00472	0.0925	CbGeAlD
Levorphanol—Cyanosis—Methotrexate—multiple sclerosis	0.00453	0.00965	CcSEcCtD
Levorphanol—Arrhythmia—Cladribine—multiple sclerosis	0.00439	0.00936	CcSEcCtD
Levorphanol—Pruritus—Fingolimod—multiple sclerosis	0.00436	0.00929	CcSEcCtD
Levorphanol—Dizziness—Fingolimod—multiple sclerosis	0.00407	0.00868	CcSEcCtD
Levorphanol—Apnoea—Methotrexate—multiple sclerosis	0.00378	0.00806	CcSEcCtD
Levorphanol—Affect lability—Prednisolone—multiple sclerosis	0.00377	0.00804	CcSEcCtD
Levorphanol—Amnesia—Methylprednisolone—multiple sclerosis	0.00374	0.00797	CcSEcCtD
Levorphanol—Cardiac arrest—Prednisolone—multiple sclerosis	0.00364	0.00776	CcSEcCtD
Levorphanol—OPRD1—nervous system—multiple sclerosis	0.00363	0.0711	CbGeAlD
Levorphanol—Mood swings—Prednisolone—multiple sclerosis	0.00363	0.00774	CcSEcCtD
Levorphanol—Arrhythmia—Azathioprine—multiple sclerosis	0.00357	0.00761	CcSEcCtD
Levorphanol—Renal failure—Mitoxantrone—multiple sclerosis	0.00354	0.00754	CcSEcCtD
Levorphanol—Confusional state—Cladribine—multiple sclerosis	0.00352	0.0075	CcSEcCtD
Levorphanol—OPRD1—central nervous system—multiple sclerosis	0.00349	0.0684	CbGeAlD
Levorphanol—OPRK1—nervous system—multiple sclerosis	0.00348	0.0681	CbGeAlD
Levorphanol—Affect lability—Triamcinolone—multiple sclerosis	0.00347	0.00739	CcSEcCtD
Levorphanol—Affect lability—Methylprednisolone—multiple sclerosis	0.00346	0.00737	CcSEcCtD
Levorphanol—Sweating—Mitoxantrone—multiple sclerosis	0.00345	0.00735	CcSEcCtD
Levorphanol—Tachycardia—Cladribine—multiple sclerosis	0.00341	0.00726	CcSEcCtD
Levorphanol—Hyperhidrosis—Cladribine—multiple sclerosis	0.00337	0.00719	CcSEcCtD
Levorphanol—OPRK1—central nervous system—multiple sclerosis	0.00335	0.0656	CbGeAlD
Levorphanol—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00335	0.00714	CcSEcCtD
Levorphanol—Hyperkinesia—Prednisone—multiple sclerosis	0.00334	0.00713	CcSEcCtD
Levorphanol—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00334	0.00712	CcSEcCtD
Levorphanol—Mood swings—Triamcinolone—multiple sclerosis	0.00334	0.00711	CcSEcCtD
Levorphanol—Mood swings—Methylprednisolone—multiple sclerosis	0.00333	0.0071	CcSEcCtD
Levorphanol—Bradycardia—Mitoxantrone—multiple sclerosis	0.00329	0.00701	CcSEcCtD
Levorphanol—OPRK1—cerebellum—multiple sclerosis	0.00327	0.0641	CbGeAlD
Levorphanol—Respiratory failure—Methotrexate—multiple sclerosis	0.00326	0.00696	CcSEcCtD
Levorphanol—Hypotension—Cladribine—multiple sclerosis	0.00326	0.00695	CcSEcCtD
Levorphanol—Lethargy—Betamethasone—multiple sclerosis	0.00326	0.00695	CcSEcCtD
Levorphanol—Lethargy—Dexamethasone—multiple sclerosis	0.00326	0.00695	CcSEcCtD
Levorphanol—Insomnia—Cladribine—multiple sclerosis	0.00316	0.00673	CcSEcCtD
Levorphanol—Affect lability—Dexamethasone—multiple sclerosis	0.00314	0.00671	CcSEcCtD
Levorphanol—Affect lability—Betamethasone—multiple sclerosis	0.00314	0.00671	CcSEcCtD
Levorphanol—Cardiac arrest—Betamethasone—multiple sclerosis	0.00304	0.00648	CcSEcCtD
Levorphanol—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00304	0.00648	CcSEcCtD
Levorphanol—Mood swings—Dexamethasone—multiple sclerosis	0.00303	0.00645	CcSEcCtD
Levorphanol—Mood swings—Betamethasone—multiple sclerosis	0.00303	0.00645	CcSEcCtD
Levorphanol—OPRM1—midbrain—multiple sclerosis	0.00301	0.0589	CbGeAlD
Levorphanol—Constipation—Cladribine—multiple sclerosis	0.00298	0.00636	CcSEcCtD
Levorphanol—Amnesia—Prednisone—multiple sclerosis	0.00296	0.00632	CcSEcCtD
Levorphanol—OPRM1—spinal cord—multiple sclerosis	0.00294	0.0575	CbGeAlD
Levorphanol—Coma—Methotrexate—multiple sclerosis	0.00293	0.00624	CcSEcCtD
Levorphanol—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00288	0.00615	CcSEcCtD
Levorphanol—Feeling abnormal—Cladribine—multiple sclerosis	0.00288	0.00613	CcSEcCtD
Levorphanol—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00285	0.00609	CcSEcCtD
Levorphanol—Lethargy—Prednisone—multiple sclerosis	0.00284	0.00606	CcSEcCtD
Levorphanol—OPRD1—brain—multiple sclerosis	0.00277	0.0543	CbGeAlD
Levorphanol—Urticaria—Cladribine—multiple sclerosis	0.00277	0.00591	CcSEcCtD
Levorphanol—Abdominal pain—Cladribine—multiple sclerosis	0.00276	0.00588	CcSEcCtD
Levorphanol—Affect lability—Prednisone—multiple sclerosis	0.00274	0.00584	CcSEcCtD
Levorphanol—Bradycardia—Prednisolone—multiple sclerosis	0.0027	0.00575	CcSEcCtD
Levorphanol—OPRK1—brain—multiple sclerosis	0.00266	0.0521	CbGeAlD
Levorphanol—Hypotension—Azathioprine—multiple sclerosis	0.00265	0.00565	CcSEcCtD
Levorphanol—Cardiac arrest—Prednisone—multiple sclerosis	0.00265	0.00564	CcSEcCtD
Levorphanol—Mood swings—Prednisone—multiple sclerosis	0.00264	0.00562	CcSEcCtD
Levorphanol—Sweating—Methylprednisolone—multiple sclerosis	0.0026	0.00554	CcSEcCtD
Levorphanol—Visual impairment—Prednisolone—multiple sclerosis	0.00255	0.00544	CcSEcCtD
Levorphanol—Bradycardia—Triamcinolone—multiple sclerosis	0.00248	0.00529	CcSEcCtD
Levorphanol—OPRM1—nervous system—multiple sclerosis	0.00247	0.0485	CbGeAlD
Levorphanol—Bradycardia—Methylprednisolone—multiple sclerosis	0.00247	0.00528	CcSEcCtD
Levorphanol—Pruritus—Cladribine—multiple sclerosis	0.00247	0.00527	CcSEcCtD
Levorphanol—Convulsion—Mitoxantrone—multiple sclerosis	0.00244	0.00519	CcSEcCtD
Levorphanol—OPRM1—central nervous system—multiple sclerosis	0.00238	0.0467	CbGeAlD
Levorphanol—Lethargy—Methotrexate—multiple sclerosis	0.00237	0.00506	CcSEcCtD
Levorphanol—Arrhythmia—Prednisolone—multiple sclerosis	0.00237	0.00505	CcSEcCtD
Levorphanol—Visual impairment—Methylprednisolone—multiple sclerosis	0.00234	0.005	CcSEcCtD
Levorphanol—Feeling abnormal—Azathioprine—multiple sclerosis	0.00234	0.00499	CcSEcCtD
Levorphanol—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00232	0.00495	CcSEcCtD
Levorphanol—Confusional state—Mitoxantrone—multiple sclerosis	0.00231	0.00493	CcSEcCtD
Levorphanol—Dizziness—Cladribine—multiple sclerosis	0.00231	0.00492	CcSEcCtD
Levorphanol—Shock—Mitoxantrone—multiple sclerosis	0.00226	0.00481	CcSEcCtD
Levorphanol—Bradycardia—Betamethasone—multiple sclerosis	0.00225	0.0048	CcSEcCtD
Levorphanol—Bradycardia—Dexamethasone—multiple sclerosis	0.00225	0.0048	CcSEcCtD
Levorphanol—Abdominal pain—Azathioprine—multiple sclerosis	0.00224	0.00478	CcSEcCtD
Levorphanol—Tachycardia—Mitoxantrone—multiple sclerosis	0.00224	0.00477	CcSEcCtD
Levorphanol—Vomiting—Cladribine—multiple sclerosis	0.00222	0.00473	CcSEcCtD
Levorphanol—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00222	0.00473	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—multiple sclerosis	0.0022	0.0047	CcSEcCtD
Levorphanol—Rash—Cladribine—multiple sclerosis	0.0022	0.00469	CcSEcCtD
Levorphanol—Dermatitis—Cladribine—multiple sclerosis	0.0022	0.00469	CcSEcCtD
Levorphanol—Arrhythmia—Triamcinolone—multiple sclerosis	0.00218	0.00464	CcSEcCtD
Levorphanol—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00217	0.00463	CcSEcCtD
Levorphanol—Hypotension—Mitoxantrone—multiple sclerosis	0.00214	0.00457	CcSEcCtD
Levorphanol—Visual impairment—Dexamethasone—multiple sclerosis	0.00213	0.00454	CcSEcCtD
Levorphanol—Visual impairment—Betamethasone—multiple sclerosis	0.00213	0.00454	CcSEcCtD
Levorphanol—Nausea—Cladribine—multiple sclerosis	0.00207	0.00442	CcSEcCtD
Levorphanol—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00202	0.00431	CcSEcCtD
Levorphanol—Convulsion—Prednisolone—multiple sclerosis	0.002	0.00426	CcSEcCtD
Levorphanol—Arrhythmia—Betamethasone—multiple sclerosis	0.00197	0.00421	CcSEcCtD
Levorphanol—Arrhythmia—Dexamethasone—multiple sclerosis	0.00197	0.00421	CcSEcCtD
Levorphanol—Constipation—Mitoxantrone—multiple sclerosis	0.00196	0.00418	CcSEcCtD
Levorphanol—Bradycardia—Prednisone—multiple sclerosis	0.00196	0.00418	CcSEcCtD
Levorphanol—OPRM1—brain—multiple sclerosis	0.00189	0.037	CbGeAlD
Levorphanol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00189	0.00403	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—multiple sclerosis	0.00188	0.00401	CcSEcCtD
Levorphanol—Dizziness—Azathioprine—multiple sclerosis	0.00188	0.004	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00188	0.004	CcSEcCtD
Levorphanol—Shock—Prednisolone—multiple sclerosis	0.00185	0.00395	CcSEcCtD
Levorphanol—Convulsion—Triamcinolone—multiple sclerosis	0.00184	0.00392	CcSEcCtD
Levorphanol—Tachycardia—Prednisolone—multiple sclerosis	0.00184	0.00392	CcSEcCtD
Levorphanol—Convulsion—Methylprednisolone—multiple sclerosis	0.00183	0.00391	CcSEcCtD
Levorphanol—Urticaria—Mitoxantrone—multiple sclerosis	0.00182	0.00389	CcSEcCtD
Levorphanol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00182	0.00388	CcSEcCtD
Levorphanol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00181	0.00387	CcSEcCtD
Levorphanol—Vomiting—Azathioprine—multiple sclerosis	0.0018	0.00385	CcSEcCtD
Levorphanol—Rash—Azathioprine—multiple sclerosis	0.00179	0.00382	CcSEcCtD
Levorphanol—Dermatitis—Azathioprine—multiple sclerosis	0.00179	0.00381	CcSEcCtD
Levorphanol—Flushing—Prednisone—multiple sclerosis	0.00179	0.00381	CcSEcCtD
Levorphanol—Dry mouth—Triamcinolone—multiple sclerosis	0.00177	0.00377	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—multiple sclerosis	0.00176	0.00376	CcSEcCtD
Levorphanol—Confusional state—Methylprednisolone—multiple sclerosis	0.00174	0.00371	CcSEcCtD
Levorphanol—Arrhythmia—Prednisone—multiple sclerosis	0.00172	0.00367	CcSEcCtD
Levorphanol—Sweating—Methotrexate—multiple sclerosis	0.00172	0.00366	CcSEcCtD
Levorphanol—Shock—Triamcinolone—multiple sclerosis	0.0017	0.00363	CcSEcCtD
Levorphanol—Insomnia—Prednisolone—multiple sclerosis	0.0017	0.00363	CcSEcCtD
Levorphanol—Shock—Methylprednisolone—multiple sclerosis	0.0017	0.00362	CcSEcCtD
Levorphanol—Tachycardia—Triamcinolone—multiple sclerosis	0.00169	0.0036	CcSEcCtD
Levorphanol—Nausea—Azathioprine—multiple sclerosis	0.00169	0.00359	CcSEcCtD
Levorphanol—Tachycardia—Methylprednisolone—multiple sclerosis	0.00169	0.00359	CcSEcCtD
Levorphanol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00167	0.00357	CcSEcCtD
Levorphanol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00167	0.00356	CcSEcCtD
Levorphanol—Convulsion—Dexamethasone—multiple sclerosis	0.00167	0.00356	CcSEcCtD
Levorphanol—Convulsion—Betamethasone—multiple sclerosis	0.00167	0.00356	CcSEcCtD
Levorphanol—Hypotension—Methylprednisolone—multiple sclerosis	0.00161	0.00344	CcSEcCtD
Levorphanol—Insomnia—Triamcinolone—multiple sclerosis	0.00157	0.00334	CcSEcCtD
Levorphanol—Insomnia—Methylprednisolone—multiple sclerosis	0.00156	0.00333	CcSEcCtD
Levorphanol—Feeling abnormal—Prednisolone—multiple sclerosis	0.00155	0.00331	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—multiple sclerosis	0.00155	0.00331	CcSEcCtD
Levorphanol—Shock—Betamethasone—multiple sclerosis	0.00154	0.00329	CcSEcCtD
Levorphanol—Shock—Dexamethasone—multiple sclerosis	0.00154	0.00329	CcSEcCtD
Levorphanol—Agitation—Prednisone—multiple sclerosis	0.00154	0.00328	CcSEcCtD
Levorphanol—Tachycardia—Betamethasone—multiple sclerosis	0.00153	0.00327	CcSEcCtD
Levorphanol—Tachycardia—Dexamethasone—multiple sclerosis	0.00153	0.00327	CcSEcCtD
Levorphanol—Dyspepsia—Triamcinolone—multiple sclerosis	0.00152	0.00325	CcSEcCtD
Levorphanol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00152	0.00324	CcSEcCtD
Levorphanol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00152	0.00324	CcSEcCtD
Levorphanol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00152	0.00324	CcSEcCtD
Levorphanol—Urticaria—Prednisolone—multiple sclerosis	0.0015	0.00319	CcSEcCtD
Levorphanol—Hypotension—Betamethasone—multiple sclerosis	0.00147	0.00313	CcSEcCtD
Levorphanol—Hypotension—Dexamethasone—multiple sclerosis	0.00147	0.00313	CcSEcCtD
Levorphanol—Vomiting—Mitoxantrone—multiple sclerosis	0.00146	0.00311	CcSEcCtD
Levorphanol—Convulsion—Prednisone—multiple sclerosis	0.00145	0.0031	CcSEcCtD
Levorphanol—Rash—Mitoxantrone—multiple sclerosis	0.00145	0.00308	CcSEcCtD
Levorphanol—Dermatitis—Mitoxantrone—multiple sclerosis	0.00145	0.00308	CcSEcCtD
Levorphanol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00143	0.00304	CcSEcCtD
Levorphanol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00142	0.00303	CcSEcCtD
Levorphanol—Insomnia—Betamethasone—multiple sclerosis	0.00142	0.00303	CcSEcCtD
Levorphanol—Insomnia—Dexamethasone—multiple sclerosis	0.00142	0.00303	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00141	0.00301	CcSEcCtD
Levorphanol—Dyspepsia—Dexamethasone—multiple sclerosis	0.00138	0.00295	CcSEcCtD
Levorphanol—Dyspepsia—Betamethasone—multiple sclerosis	0.00138	0.00295	CcSEcCtD
Levorphanol—Urticaria—Triamcinolone—multiple sclerosis	0.00137	0.00293	CcSEcCtD
Levorphanol—Urticaria—Methylprednisolone—multiple sclerosis	0.00137	0.00293	CcSEcCtD
Levorphanol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00137	0.00291	CcSEcCtD
Levorphanol—Nausea—Mitoxantrone—multiple sclerosis	0.00136	0.00291	CcSEcCtD
Levorphanol—Shock—Prednisone—multiple sclerosis	0.00135	0.00287	CcSEcCtD
Levorphanol—Tachycardia—Prednisone—multiple sclerosis	0.00133	0.00285	CcSEcCtD
Levorphanol—Hyperhidrosis—Prednisone—multiple sclerosis	0.00132	0.00282	CcSEcCtD
Levorphanol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00129	0.00276	CcSEcCtD
Levorphanol—Feeling abnormal—Betamethasone—multiple sclerosis	0.00129	0.00276	CcSEcCtD
Levorphanol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00128	0.00274	CcSEcCtD
Levorphanol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00128	0.00274	CcSEcCtD
Levorphanol—Urticaria—Dexamethasone—multiple sclerosis	0.00125	0.00266	CcSEcCtD
Levorphanol—Urticaria—Betamethasone—multiple sclerosis	0.00125	0.00266	CcSEcCtD
Levorphanol—Dizziness—Prednisolone—multiple sclerosis	0.00124	0.00265	CcSEcCtD
Levorphanol—Abdominal pain—Betamethasone—multiple sclerosis	0.00124	0.00265	CcSEcCtD
Levorphanol—Abdominal pain—Dexamethasone—multiple sclerosis	0.00124	0.00265	CcSEcCtD
Levorphanol—Insomnia—Prednisone—multiple sclerosis	0.00124	0.00264	CcSEcCtD
Levorphanol—Pruritus—Triamcinolone—multiple sclerosis	0.00122	0.00261	CcSEcCtD
Levorphanol—Pruritus—Methylprednisolone—multiple sclerosis	0.00122	0.00261	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—multiple sclerosis	0.00121	0.00259	CcSEcCtD
Levorphanol—Dyspepsia—Prednisone—multiple sclerosis	0.0012	0.00257	CcSEcCtD
Levorphanol—Rash—Prednisolone—multiple sclerosis	0.00119	0.00253	CcSEcCtD
Levorphanol—Dermatitis—Prednisolone—multiple sclerosis	0.00119	0.00253	CcSEcCtD
Levorphanol—Constipation—Prednisone—multiple sclerosis	0.00117	0.00249	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—multiple sclerosis	0.00115	0.00246	CcSEcCtD
Levorphanol—Dizziness—Triamcinolone—multiple sclerosis	0.00114	0.00244	CcSEcCtD
Levorphanol—Dizziness—Methylprednisolone—multiple sclerosis	0.00114	0.00244	CcSEcCtD
Levorphanol—Feeling abnormal—Prednisone—multiple sclerosis	0.00113	0.0024	CcSEcCtD
Levorphanol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00112	0.00238	CcSEcCtD
Levorphanol—Nausea—Prednisolone—multiple sclerosis	0.00112	0.00238	CcSEcCtD
Levorphanol—Pruritus—Dexamethasone—multiple sclerosis	0.00111	0.00237	CcSEcCtD
Levorphanol—Pruritus—Betamethasone—multiple sclerosis	0.00111	0.00237	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.0011	0.00236	CcSEcCtD
Levorphanol—Vomiting—Triamcinolone—multiple sclerosis	0.0011	0.00235	CcSEcCtD
Levorphanol—Vomiting—Methylprednisolone—multiple sclerosis	0.0011	0.00234	CcSEcCtD
Levorphanol—OPRD1—GPCR ligand binding—CNR1—multiple sclerosis	0.0011	0.00228	CbGpPWpGaD
Levorphanol—Rash—Triamcinolone—multiple sclerosis	0.00109	0.00233	CcSEcCtD
Levorphanol—OPRD1—Signaling by GPCR—RGS1—multiple sclerosis	0.00109	0.00227	CbGpPWpGaD
Levorphanol—Dermatitis—Triamcinolone—multiple sclerosis	0.00109	0.00232	CcSEcCtD
Levorphanol—Rash—Methylprednisolone—multiple sclerosis	0.00109	0.00232	CcSEcCtD
Levorphanol—Dermatitis—Methylprednisolone—multiple sclerosis	0.00109	0.00232	CcSEcCtD
Levorphanol—Urticaria—Prednisone—multiple sclerosis	0.00109	0.00232	CcSEcCtD
Levorphanol—Abdominal pain—Prednisone—multiple sclerosis	0.00108	0.00231	CcSEcCtD
Levorphanol—OPRK1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00107	0.00223	CbGpPWpGaD
Levorphanol—Hypotension—Methotrexate—multiple sclerosis	0.00107	0.00228	CcSEcCtD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00107	0.00222	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00105	0.00219	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00105	0.00218	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00104	0.00217	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00104	0.00217	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CCR2—multiple sclerosis	0.00104	0.00217	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00104	0.00217	CbGpPWpGaD
Levorphanol—Dizziness—Dexamethasone—multiple sclerosis	0.00104	0.00221	CcSEcCtD
Levorphanol—Dizziness—Betamethasone—multiple sclerosis	0.00104	0.00221	CcSEcCtD
Levorphanol—OPRD1—Signaling by GPCR—GPR65—multiple sclerosis	0.00103	0.00215	CbGpPWpGaD
Levorphanol—Insomnia—Methotrexate—multiple sclerosis	0.00103	0.0022	CcSEcCtD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00103	0.00214	CbGpPWpGaD
Levorphanol—Nausea—Triamcinolone—multiple sclerosis	0.00103	0.00219	CcSEcCtD
Levorphanol—OPRK1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00103	0.00214	CbGpPWpGaD
Levorphanol—Nausea—Methylprednisolone—multiple sclerosis	0.00103	0.00219	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—multiple sclerosis	0.00101	0.00215	CcSEcCtD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00101	0.00209	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.001	0.00209	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LINGO1—multiple sclerosis	0.001	0.00208	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000999	0.00208	CbGpPWpGaD
Levorphanol—Vomiting—Dexamethasone—multiple sclerosis	0.000998	0.00213	CcSEcCtD
Levorphanol—Vomiting—Betamethasone—multiple sclerosis	0.000998	0.00213	CcSEcCtD
Levorphanol—Rash—Betamethasone—multiple sclerosis	0.00099	0.00211	CcSEcCtD
Levorphanol—Rash—Dexamethasone—multiple sclerosis	0.00099	0.00211	CcSEcCtD
Levorphanol—Dermatitis—Betamethasone—multiple sclerosis	0.000989	0.00211	CcSEcCtD
Levorphanol—Dermatitis—Dexamethasone—multiple sclerosis	0.000989	0.00211	CcSEcCtD
Levorphanol—OPRD1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000988	0.00206	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000987	0.00206	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000978	0.00204	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.000973	0.00203	CbGpPWpGaD
Levorphanol—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.000971	0.00202	CbGpPWpGaD
Levorphanol—Pruritus—Prednisone—multiple sclerosis	0.000968	0.00206	CcSEcCtD
Levorphanol—OPRK1—GPCR ligand binding—CNR1—multiple sclerosis	0.000961	0.002	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000961	0.002	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.000957	0.00199	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000951	0.00198	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000946	0.00197	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.000946	0.00197	CbGpPWpGaD
Levorphanol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000942	0.00201	CcSEcCtD
Levorphanol—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000937	0.00195	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000937	0.00195	CbGpPWpGaD
Levorphanol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000935	0.00199	CcSEcCtD
Levorphanol—Nausea—Dexamethasone—multiple sclerosis	0.000933	0.00199	CcSEcCtD
Levorphanol—Nausea—Betamethasone—multiple sclerosis	0.000933	0.00199	CcSEcCtD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000913	0.0019	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000913	0.0019	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.00091	0.0019	CbGpPWpGaD
Levorphanol—Urticaria—Methotrexate—multiple sclerosis	0.000908	0.00194	CcSEcCtD
Levorphanol—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.000907	0.00189	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000905	0.00189	CbGpPWpGaD
Levorphanol—Dizziness—Prednisone—multiple sclerosis	0.000904	0.00193	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—multiple sclerosis	0.000903	0.00193	CcSEcCtD
Levorphanol—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000892	0.00186	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00089	0.00186	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000881	0.00184	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.00088	0.00183	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.000877	0.00183	CbGpPWpGaD
Levorphanol—Vomiting—Prednisone—multiple sclerosis	0.00087	0.00185	CcSEcCtD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00087	0.00181	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000868	0.00181	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000867	0.00181	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000866	0.00181	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000866	0.0018	CbGpPWpGaD
Levorphanol—Rash—Prednisone—multiple sclerosis	0.000862	0.00184	CcSEcCtD
Levorphanol—Dermatitis—Prednisone—multiple sclerosis	0.000861	0.00184	CcSEcCtD
Levorphanol—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.00085	0.00177	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000849	0.00177	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000844	0.00176	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00083	0.00173	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.00083	0.00173	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000827	0.00172	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000812	0.00169	CbGpPWpGaD
Levorphanol—Nausea—Prednisone—multiple sclerosis	0.000812	0.00173	CcSEcCtD
Levorphanol—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000809	0.00168	CbGpPWpGaD
Levorphanol—Pruritus—Methotrexate—multiple sclerosis	0.000809	0.00172	CcSEcCtD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000786	0.00164	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000772	0.00161	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000772	0.00161	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000769	0.0016	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000767	0.0016	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.000765	0.00159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.00076	0.00158	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000758	0.00158	CbGpPWpGaD
Levorphanol—Dizziness—Methotrexate—multiple sclerosis	0.000756	0.00161	CcSEcCtD
Levorphanol—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000745	0.00155	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000745	0.00155	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000741	0.00154	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000737	0.00154	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000732	0.00153	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000732	0.00152	CbGpPWpGaD
Levorphanol—Vomiting—Methotrexate—multiple sclerosis	0.000727	0.00155	CcSEcCtD
Levorphanol—Rash—Methotrexate—multiple sclerosis	0.000721	0.00154	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—multiple sclerosis	0.00072	0.00154	CcSEcCtD
Levorphanol—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000715	0.00149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000701	0.00146	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000701	0.00146	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00069	0.00144	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000689	0.00144	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000686	0.00143	CbGpPWpGaD
Levorphanol—Nausea—Methotrexate—multiple sclerosis	0.000679	0.00145	CcSEcCtD
Levorphanol—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000674	0.0014	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000674	0.0014	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000671	0.0014	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000671	0.0014	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.000665	0.00138	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000649	0.00135	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.000647	0.00135	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000645	0.00134	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000643	0.00134	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.00063	0.00131	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000627	0.00131	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000627	0.00131	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00062	0.00129	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000611	0.00127	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.00061	0.00127	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000605	0.00126	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000598	0.00125	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000591	0.00123	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000589	0.00123	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000585	0.00122	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000582	0.00121	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00057	0.00119	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000569	0.00119	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000567	0.00118	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000565	0.00118	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000563	0.00117	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000562	0.00117	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000559	0.00116	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000559	0.00116	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000558	0.00116	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00055	0.00114	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000546	0.00114	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000543	0.00113	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000536	0.00112	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000535	0.00111	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00053	0.0011	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000525	0.00109	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000513	0.00107	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000511	0.00107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000507	0.00106	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.0005	0.00104	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000498	0.00104	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000493	0.00103	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.00049	0.00102	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.00049	0.00102	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000489	0.00102	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000481	0.001	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.00048	0.001	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000478	0.000995	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000464	0.000968	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000459	0.000957	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000453	0.000943	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000452	0.000941	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000444	0.000925	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000443	0.000924	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.000436	0.000908	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000434	0.000904	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000433	0.000901	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000426	0.000888	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000421	0.000877	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000417	0.000869	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000414	0.000863	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000414	0.000863	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000413	0.000861	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.000398	0.00083	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.000393	0.000818	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000387	0.000807	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.000383	0.000799	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	0.000382	0.000797	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000379	0.00079	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.000377	0.000786	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000375	0.000782	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000374	0.000779	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.00037	0.000771	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.000367	0.000764	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	0.00036	0.00075	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000356	0.000741	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	0.000349	0.000727	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	0.000344	0.000718	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000339	0.000707	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	0.000338	0.000704	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	0.000336	0.0007	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	0.000332	0.000692	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PGR—multiple sclerosis	0.000331	0.00069	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	0.000325	0.000676	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000323	0.000673	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CD28—multiple sclerosis	0.000322	0.00067	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000321	0.000668	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000316	0.000658	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	0.000316	0.000658	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	0.000307	0.00064	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	0.0003	0.000626	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	0.000299	0.000623	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	0.000296	0.000618	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000295	0.000615	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	0.000291	0.000607	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000291	0.000607	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000287	0.000598	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000284	0.000592	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PGR—multiple sclerosis	0.00028	0.000583	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000274	0.000572	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000273	0.000568	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CD28—multiple sclerosis	0.000272	0.000566	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	0.000269	0.000561	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000267	0.000556	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	0.000263	0.000549	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	0.000262	0.000547	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CD86—multiple sclerosis	0.000262	0.000545	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	0.000258	0.000537	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000251	0.000522	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	0.00025	0.000521	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000246	0.000513	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	0.000239	0.000498	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	0.000239	0.000497	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	0.000232	0.000483	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CD86—multiple sclerosis	0.000229	0.000478	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	0.000229	0.000476	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	0.000228	0.000474	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	0.000227	0.000473	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	0.000226	0.000471	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	0.000223	0.000464	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	0.000222	0.000462	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	0.000219	0.000457	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOE—multiple sclerosis	0.000211	0.00044	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	0.000209	0.000436	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	0.000203	0.000424	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	0.000202	0.000421	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	0.000201	0.000418	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	0.000199	0.000415	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CD86—multiple sclerosis	0.000194	0.000404	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	0.000191	0.000398	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CD80—multiple sclerosis	0.000191	0.000398	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	0.000185	0.000386	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOE—multiple sclerosis	0.000185	0.000386	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—POMC—multiple sclerosis	0.000181	0.000378	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	0.000177	0.00037	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	0.000177	0.000368	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000174	0.000362	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	0.000172	0.000358	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	0.000169	0.000353	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	0.000168	0.00035	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CD80—multiple sclerosis	0.000167	0.000349	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	0.000161	0.000336	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—POMC—multiple sclerosis	0.000159	0.000331	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOE—multiple sclerosis	0.000156	0.000326	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	0.000156	0.000324	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000152	0.000317	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CD80—multiple sclerosis	0.000141	0.000295	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	0.000141	0.000294	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—POMC—multiple sclerosis	0.000134	0.00028	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2—multiple sclerosis	0.000134	0.000279	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	0.000133	0.000278	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	0.000132	0.000274	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000129	0.000268	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	0.000127	0.000264	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	0.000119	0.000249	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2—multiple sclerosis	0.000118	0.000245	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	0.000117	0.000244	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	0.000113	0.000235	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	0.000111	0.000232	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—multiple sclerosis	0.000105	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	0.000105	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	0.000103	0.000214	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2—multiple sclerosis	9.94e-05	0.000207	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	9.89e-05	0.000206	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	9.89e-05	0.000206	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	9.4e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—multiple sclerosis	9.19e-05	0.000192	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	9.17e-05	0.000191	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	8.99e-05	0.000187	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	8.36e-05	0.000174	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—multiple sclerosis	7.88e-05	0.000164	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—multiple sclerosis	7.77e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	7.75e-05	0.000161	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	7.6e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—multiple sclerosis	6.91e-05	0.000144	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—multiple sclerosis	5.84e-05	0.000122	CbGpPWpGaD
